IDH1 c.1057_1058del ;(p.A353Lfs*12)

Variant ID: 2-209103891-GGC-G

NM_005896.2(IDH1):c.1057_1058del;(p.A353Lfs*12)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux.

Oncotarget
Ilina, Elena I EI; Armento, Angela A; Sanchez, Leticia Garea LG; Reichlmeir, Marina M; Braun, Yannick Y; Penski, Cornelia C; Capper, David D; Sahm, Felix F; Jennewein, Lukas L; Harter, Patrick N PN; Zukunft, Sven S; Fleming, Ingrid I; Schulte, Dorothea D; Le Guerroué, Francois F; Behrends, Christian C; Ronellenfitsch, Michael W MW; Naumann, Ulrike U; Mittelbronn, Michel M
Publication Date: 2017-09-15

Variant appearance in text: IDH1: 1057_1058del
PubMed Link: 28978054
Variant Present in the following documents:
  • Main text
View BVdb publication page